ACTIVATION OF BONE MORPHOGENETIC PROTEIN (BMP) GENE EXPRESSION IN BONE CELLS BY MEANS OF ELECTROMAGNETIC SIGNALS Russian patent published in 2010 - IPC C12N5/02 A01N63/00 

Abstract RU 2388817 C2

FIELD: biotechnologies.

SUBSTANCE: device generates one specific and selective signal, which has sinusoid configuration of wave and when applied to electrodes, coils or other field-generating devices, it results in generation of electric field, having amplitude of approximately 20 mV/cm in bone tissue at 60 kHz with approximately 50% cyclic mode. Specified electric field is specific and selective for activation of bone morphogenetic protein (BMP) gene expression measured by messenger RNA in specified bone tissue.

EFFECT: efficient treatment of bone fracture, prevention of fracture risk, slow knitting, non-unions, bone defects, arthrodesis of vertebrae, osteonecrosis and osteoporosis.

6 cl, 8 dwg, 1 ex

Similar patents RU2388817C2

Title Year Author Number
BONE LOSS TREATMENT AND PREVENTION METHOD 2007
  • Allard Dzhon Dejvid
  • Klejn Robert Frederik
  • Peltz Gehri Allen
RU2358728C2
GENE-THERAPY DNA-VECTOR BASED ON GENE-THERAPY DNA-VECTOR VTVAF17, CARRYING TARGET GENE SELECTED FROM GROUP OF GENES BMP-2, BMP-7, LMP-1, NELL-1 TO INCREASE EXPRESSION LEVEL OF THESE TARGET GENES, METHOD FOR PRODUCTION AND APPLICATION THEREOF, STRAIN ESCHERICHIA COLI SCS110-AF/VTVAF17-BMP-2, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-BMP-7, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-LMP-1, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-NELL-1, CARRYING GENE-THERAPY DNA VECTOR, METHOD FOR PRODUCTION THEREOF, METHOD FOR INDUSTRIAL PRODUCTION OF GENE-THERAPY DNA VECTOR 2018
  • Savelieva Natalia
RU2720521C1
COMPOSITIONS AND METHODS OF TREATING MPS1 2014
  • Uilson Dzhejms M.
  • Gurda Brittni L.
RU2708318C2
ERYTHROFERRONE AND ERFE POLYPEPTIDES AND METHODS FOR REGULATING IRON METABOLISM 2013
  • Ganz Tomas
  • Nemet Elizabeta
  • Kautts Leon
RU2684216C2
METHODS AND COMPONENTS FOR INDUCTION OF TUMOR- -SPECIFIC CYTOTOXICITY 1998
  • Khokhberg Abrakham
  • Ajesh Sukhail
RU2214280C2
INTERFERON PRODRUG FOR CANCER TREATMENT 2018
  • Fu, Yang-Xin
  • Cao, Xuezhi
RU2788736C2
METHODS FOR BONE CANCER RELATED PAIN MANAGEMENT BY ADMINISTRATION OF NERVE GROWTH FACTOR ANTAGONIST 2005
  • Shelton Dehvid L.
  • Mantikh Patrik Uill'Jam
RU2389509C2
MORPHOGENE BONE PROTEINS (BMP), BMP RECEPTORS AND BINDING BMP PROTEINS AND THEIR APPLICATION FOR DIAGNOSTICS AND GLAUCOMA TREATMENT 2002
  • Klark Ehbbot F.
  • Uordinger Robert Dzh.
RU2336902C2
TRANSIENT CELLULAR REPROGRAMMING TO REVERSE CELL AGING 2019
  • Sebastiano, Vittorio
  • Sarkar, Tapash Jay
RU2801316C2
FACTOR EFFECTING ON ACTIVITY OF TUMOR NECROSIS FACTOR RECEPTOR-RELEASING ENZYME 1999
  • Gatanaga Tetsuja
  • Grehndzher Gejl A.
RU2279478C2

RU 2 388 817 C2

Authors

Brajton Karl T.

Dates

2010-05-10Published

2005-01-11Filed